Impact of MetS on Long-Term Prognosis Among STEMI Patients Treated with pPCI—Ten-Year Follow-Up Study

Background/Objectives: Metabolic syndrome (MetS) affects more than 1.5 billion adults worldwide and is present in 37–70% of STEMI patients. Its ten-year prognostic value after primary PCI—particularly for heart failure, which is rarely examined as a primary endpoint—remains incompletely characterize...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Milan B. Lović, Dragan B. Đorđević, Sandra B. Šarić, Ivan S. Tasić, Dejana D. Isaković, Jovana Lj. Kostić
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2026-05-01
Sarja:	Medical Sciences
Aiheet:	metabolic syndrome ST-segment elevation myocardial infarction primary percutaneous coronary intervention heart failure major adverse cardiovascular events obesity paradox
Linkit:	https://www.mdpi.com/2076-3271/14/2/268
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!